Stada Arzneimittel AG operates in the Pharmaceutical preparations sector. STADA Arzneimittel AG (STADA) is a Germany-based company active in the pharmaceutical sector. STADA concentrates on the development and marketing of products with off-patent active pharmaceutical ingredients. The Company's primary business segments are: Generics, comprising low-priced and active-ingredient products, and Branded Products, focusing on multisource products that are accessible without active ingredient research. STADA's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities, as well as Group holdings/other segment. As of March 1, 2011, STADA operated with 38 subsidiaries in 25 national markets in Europe and was active with its own sales companies in China, Kazakhstan, the Philippines, Thailand and Vietnam, as well as in Africa with a sales company in Egypt. In our complete report available for purchase the company is compared to: Actelion AG, Meda Ab and Alapis S.A..